Homoharringtonine is effective in accelerated phase of chronic myeloid leukemia.

被引：0
|
作者：
Chen, CI
MacKinnon, J
Yee, K
Kamel-Reid, S
Crump, M
Keating, A
机构：
[1] Toronto Hosp, Toronto, ON M5T 2S8, Canada
[2] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4042
引用
收藏
页码：242B / 242B
页数：1
相关论文
共 50 条
  • [1] Accelerated and blastic phase of chronic myeloid leukemia.
    Dutcher J.P.
    Wiernik P.H.
    [J]. Current Treatment Options in Oncology, 2000, 1 (1) : 51 - 62
  • [2] Assessment of the criteria for the accelerated phase of chronic myeloid leukemia.
    Cervantes, F
    LopezGuillermo, A
    Bosch, F
    Terol, MJ
    Montserrat, E
    Rozman, C
    [J]. BLOOD, 1995, 86 (10) : 3157 - 3157
  • [3] Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia
    Maiti, Abhishek
    Cortes, Jorge
    Ferrajoli, Alessandra
    Estrov, Zeev
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Ravandi, Farhad
    O'Brien, Susan
    Kantarjian, Hagop
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2240 - 2242
  • [4] Homoharringtonine (HHT) with Imatinib in Chronic, Accelerated, and Blast Phase Chronic Myeloid Leukemia (CML)
    Maiti, Abhishek
    Kantarjian, Hagop M.
    Ferrajoli, Alessandra
    Estrov, Zeev
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Ravandi, Farhad
    O'Brien, Susan M.
    Cortes, Jorge E.
    [J]. BLOOD, 2016, 128 (22)
  • [5] Results of the clinical. use of the combination regiment of homoharringtonine (HHT) and cytarabine in the management of late chronic phase and accelerated phase chronic myelogenous leukemia.
    De Sarrazin, A
    Fohrer, C
    Madelaine-Chambrin, I
    Dumont, J
    Najman, A
    Vehkkof, J
    Briere, J
    Solal-Celigny, P
    Decaudin, D
    Boulanger, E
    Guillemin, F
    Legros, L
    Larghero, J
    Robin, JP
    Maloisel, F
    Rousselot, P
    [J]. BLOOD, 2001, 98 (11) : 350A - 350A
  • [6] Semi-synthetic homoharringtonine (Myelostat®) for chronic myeloid leukemia in accelerated phase after imatinib failure.
    Burton, CH
    Ranger, A
    Nadal, E
    Avery, S
    Nathan, I
    Apperley, JF
    Goldman, JM
    Marin, D
    [J]. BLOOD, 2003, 102 (11) : 908A - 909A
  • [7] Homoharringtonine (HHT) for chronic myeloid leukemia in accelerated phase (CML AP): A follow-up study.
    Al-Beirouti, BM
    Chen, C
    Yee, K
    Kamel-Reid, S
    Keating, A
    [J]. BLOOD, 2001, 98 (11) : 254B - 255B
  • [8] THE ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA
    ZANKOVICH, R
    THIELE, J
    FISCHER, R
    DIEHL, V
    [J]. MEDIZINISCHE KLINIK, 1986, 81 (07) : 245 - 250
  • [9] Effect of homoharringtonine on maturation and function of dendritic cells derived from patients with chronic myeloid leukemia.
    Wang, C
    Zhao, CX
    Liu, WW
    Yan, SK
    Gao, YR
    Cai, Q
    Wei, DL
    [J]. BLOOD, 2003, 102 (11) : 317B - 317B
  • [10] Homoharringtonine (HHT) plus cytarabine (Ara-C) for chronic myeloid leukemia in accelerated phase (CML-AP).
    Maloisel, F
    De Sarrazin, A
    Fohrer, C
    Rousselot, P
    Maisonneuve, H
    Lucas, P
    Campos, F
    Dufour, P
    Bergerat, JP
    [J]. BLOOD, 2001, 98 (11) : 262B - 262B
12345